Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Authors:

Abstract
No abstract available
Funding Information
  • Novartis

This publication has 27 references indexed in Scilit: